09:54 AM EST - Avai Bio Inc : Announced--together with its joint venture partner and global biotechnology firm, Austrianova--the initiation of production for a Master Cell Bank of genetically modified cells that overexpress the a-Klotho protein. These cells will enable Klothonova, the parties' joint venture, to advance its anti-aging product candidate within the ongoing a-Klotho development program, following the successful completion of all preparatory activities in February. Avai Bio Inc
shares O.AVAI are trading off $0.02 at $0.38.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=8658847033485657
